Form 4 Filing for IMMUNIC, INC.

This filing details a Form 4 submission for IMMUNIC, INC. (IMUX) by Simona Skerjanec, who is a director. On June 29, 2026, Ms. Skerjanec was granted 25,370 stock options with an exercise price of $0.00, vesting immediately. These options are for the company's Common Stock and are set to expire on March 27, 2036. The grant was conditionally approved by the Board of Directors on March 27, 2026, pending stockholder approval of an amendment to the company's 2019 Omnibus Equity Incentive Plan, which was obtained at the 2026 Annual Meeting of Stockholders held on June 29, 2026. Following this transaction, Ms. Skerjanec holds 25,370 shares.